版本:
中国

BRIEF-Rosetta Genomics announces pricing of $5 million concurrent registered direct and private placement offering

Nov 23 Rosetta Genomics Ltd -

* Entered into definitive agreements with one institutional healthcare investor to purchase an aggregate of 1.1 million ordinary shares

* Entered into definitive agreements to purchase up to 10 million ordinary shares in a concurrent private placement

* Rosetta Genomics announces pricing of $5 million concurrent registered direct and private placement offering Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐